nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—SLC22A2—Probenecid—gout	0.199	0.535	CbGbCtD
Pramipexole—SLC22A1—Probenecid—gout	0.173	0.465	CbGbCtD
Pramipexole—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A11—gout	0.0102	0.108	CbGpPWpGaD
Pramipexole—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A11—gout	0.00947	0.1	CbGpPWpGaD
Pramipexole—SLC22A2—Abacavir transmembrane transport—ABCG2—gout	0.00808	0.0856	CbGpPWpGaD
Pramipexole—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—gout	0.0077	0.0816	CbGpPWpGaD
Pramipexole—SLC22A1—Abacavir transmembrane transport—ABCG2—gout	0.00753	0.0798	CbGpPWpGaD
Pramipexole—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—gout	0.00718	0.076	CbGpPWpGaD
Pramipexole—SLC22A2—Abacavir transport and metabolism—ABCG2—gout	0.00464	0.0491	CbGpPWpGaD
Pramipexole—SLC22A1—Abacavir transport and metabolism—ABCG2—gout	0.00432	0.0458	CbGpPWpGaD
Pramipexole—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.00204	0.0216	CbGpPWpGaD
Pramipexole—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.0019	0.0201	CbGpPWpGaD
Pramipexole—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.00154	0.0163	CbGpPWpGaD
Pramipexole—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.00144	0.0152	CbGpPWpGaD
Pramipexole—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.00143	0.0152	CbGpPWpGaD
Pramipexole—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.00134	0.0142	CbGpPWpGaD
Pramipexole—SLC22A2—SLC-mediated transmembrane transport—SLC17A1—gout	0.000925	0.0098	CbGpPWpGaD
Pramipexole—SLC22A2—SLC-mediated transmembrane transport—SLC22A11—gout	0.000925	0.0098	CbGpPWpGaD
Pramipexole—SLC22A1—SLC-mediated transmembrane transport—SLC22A11—gout	0.000862	0.00913	CbGpPWpGaD
Pramipexole—SLC22A1—SLC-mediated transmembrane transport—SLC17A1—gout	0.000862	0.00913	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—LRRC16A—gout	0.000816	0.00864	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—LRRC16A—gout	0.000762	0.00807	CbGpPWpGaD
Pramipexole—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—gout	0.000701	0.00743	CbGpPWpGaD
Pramipexole—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—gout	0.000653	0.00692	CbGpPWpGaD
Pramipexole—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—gout	0.000652	0.0069	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—LRRC16A—gout	0.000619	0.00656	CbGpPWpGaD
Pramipexole—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—gout	0.000607	0.00643	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—SLC17A3—gout	0.000577	0.00611	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC17A3—gout	0.000537	0.00569	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—SLC17A1—gout	0.00047	0.00498	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—SLC22A11—gout	0.00047	0.00498	CbGpPWpGaD
Pramipexole—DRD5—G alpha (s) signalling events—POMC—gout	0.000466	0.00494	CbGpPWpGaD
Pramipexole—HTR1A—SIDS Susceptibility Pathways—IL1RN—gout	0.000438	0.00464	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC17A1—gout	0.000438	0.00464	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC22A11—gout	0.000438	0.00464	CbGpPWpGaD
Pramipexole—HTR2A—SIDS Susceptibility Pathways—IL1RN—gout	0.000379	0.00401	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—SLC22A12—gout	0.000356	0.00377	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC22A12—gout	0.000332	0.00352	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—SLC2A9—gout	0.000331	0.00351	CbGpPWpGaD
Pramipexole—DRD1—G alpha (s) signalling events—POMC—gout	0.00031	0.00328	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC2A9—gout	0.000309	0.00327	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—BCKDHA—gout	0.00027	0.00286	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—BCKDHA—gout	0.000263	0.00278	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—BCKDHA—gout	0.000252	0.00267	CbGpPWpGaD
Pramipexole—Purpura—Prednisone—gout	0.000238	0.000446	CcSEcCtD
Pramipexole—Infestation—Hydrocortisone—gout	0.000237	0.000445	CcSEcCtD
Pramipexole—Infestation NOS—Hydrocortisone—gout	0.000237	0.000445	CcSEcCtD
Pramipexole—Pruritus—Allopurinol—gout	0.000237	0.000444	CcSEcCtD
Pramipexole—Conjunctivitis—Prednisolone—gout	0.000236	0.000443	CcSEcCtD
Pramipexole—Cardiac failure—Prednisone—gout	0.000235	0.00044	CcSEcCtD
Pramipexole—Vomiting—Indomethacin—gout	0.000234	0.000439	CcSEcCtD
Pramipexole—Acute coronary syndrome—Hydrocortisone—gout	0.000234	0.000439	CcSEcCtD
Pramipexole—Lethargy—Prednisone—gout	0.000234	0.000439	CcSEcCtD
Pramipexole—Myocardial infarction—Hydrocortisone—gout	0.000233	0.000436	CcSEcCtD
Pramipexole—Neuropathy peripheral—Hydrocortisone—gout	0.000233	0.000436	CcSEcCtD
Pramipexole—Rash—Indomethacin—gout	0.000232	0.000436	CcSEcCtD
Pramipexole—Dermatitis—Indomethacin—gout	0.000232	0.000435	CcSEcCtD
Pramipexole—Urticaria—Naproxen—gout	0.000232	0.000435	CcSEcCtD
Pramipexole—Headache—Indomethacin—gout	0.000231	0.000433	CcSEcCtD
Pramipexole—Body temperature increased—Naproxen—gout	0.000231	0.000433	CcSEcCtD
Pramipexole—Abdominal pain—Naproxen—gout	0.000231	0.000433	CcSEcCtD
Pramipexole—Nausea—Colchicine—gout	0.00023	0.000432	CcSEcCtD
Pramipexole—Osteoarthritis—Prednisone—gout	0.000229	0.00043	CcSEcCtD
Pramipexole—Gastrointestinal haemorrhage—Prednisone—gout	0.000229	0.00043	CcSEcCtD
Pramipexole—Diarrhoea—Allopurinol—gout	0.000229	0.000429	CcSEcCtD
Pramipexole—Weight increased—Methylprednisolone—gout	0.000228	0.000427	CcSEcCtD
Pramipexole—Affect lability—Prednisone—gout	0.000226	0.000423	CcSEcCtD
Pramipexole—Psychotic disorder—Prednisone—gout	0.000224	0.00042	CcSEcCtD
Pramipexole—Infestation NOS—Methylprednisolone—gout	0.000223	0.000418	CcSEcCtD
Pramipexole—Infestation—Methylprednisolone—gout	0.000223	0.000418	CcSEcCtD
Pramipexole—DRD5—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000222	0.00236	CbGpPWpGaD
Pramipexole—Bradycardia—Prednisolone—gout	0.000222	0.000417	CcSEcCtD
Pramipexole—Face oedema—Prednisone—gout	0.000221	0.000415	CcSEcCtD
Pramipexole—Dizziness—Allopurinol—gout	0.000221	0.000415	CcSEcCtD
Pramipexole—SLC22A2—Metabolism—PRPS2—gout	0.00022	0.00233	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—HPRT1—gout	0.00022	0.00233	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PRPS1—gout	0.00022	0.00233	CbGpPWpGaD
Pramipexole—Acute coronary syndrome—Methylprednisolone—gout	0.00022	0.000412	CcSEcCtD
Pramipexole—Nausea—Indomethacin—gout	0.000219	0.00041	CcSEcCtD
Pramipexole—Irritability—Prednisone—gout	0.000219	0.00041	CcSEcCtD
Pramipexole—Neuropathy peripheral—Methylprednisolone—gout	0.000219	0.00041	CcSEcCtD
Pramipexole—Myocardial infarction—Methylprednisolone—gout	0.000219	0.00041	CcSEcCtD
Pramipexole—Cardiac arrest—Prednisone—gout	0.000218	0.000409	CcSEcCtD
Pramipexole—Mood swings—Prednisone—gout	0.000217	0.000407	CcSEcCtD
Pramipexole—Bradycardia—Hydrocortisone—gout	0.000217	0.000407	CcSEcCtD
Pramipexole—Hypersensitivity—Naproxen—gout	0.000215	0.000403	CcSEcCtD
Pramipexole—HTR1D—G alpha (i) signalling events—POMC—gout	0.000214	0.00227	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PRPS1—gout	0.000214	0.00227	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PRPS2—gout	0.000214	0.00227	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—HPRT1—gout	0.000214	0.00227	CbGpPWpGaD
Pramipexole—Sweating—Methylprednisolone—gout	0.000214	0.000401	CcSEcCtD
Pramipexole—ADRA2A—Metabolism—BCKDHA—gout	0.000213	0.00226	CbGpPWpGaD
Pramipexole—Vomiting—Allopurinol—gout	0.000213	0.000399	CcSEcCtD
Pramipexole—Hallucination—Hydrocortisone—gout	0.000212	0.000398	CcSEcCtD
Pramipexole—Rash—Allopurinol—gout	0.000211	0.000395	CcSEcCtD
Pramipexole—Dermatitis—Allopurinol—gout	0.000211	0.000395	CcSEcCtD
Pramipexole—Visual impairment—Prednisolone—gout	0.00021	0.000394	CcSEcCtD
Pramipexole—Dry skin—Prednisone—gout	0.00021	0.000394	CcSEcCtD
Pramipexole—HTR1B—G alpha (i) signalling events—POMC—gout	0.00021	0.00222	CbGpPWpGaD
Pramipexole—Headache—Allopurinol—gout	0.000209	0.000393	CcSEcCtD
Pramipexole—Asthenia—Naproxen—gout	0.000209	0.000393	CcSEcCtD
Pramipexole—Connective tissue disorder—Hydrocortisone—gout	0.000209	0.000393	CcSEcCtD
Pramipexole—Hypokalaemia—Prednisone—gout	0.000209	0.000391	CcSEcCtD
Pramipexole—Pruritus—Naproxen—gout	0.000207	0.000387	CcSEcCtD
Pramipexole—DRD4—G alpha (i) signalling events—POMC—gout	0.000206	0.00219	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—HPRT1—gout	0.000205	0.00217	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PRPS1—gout	0.000205	0.00217	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PRPS2—gout	0.000205	0.00217	CbGpPWpGaD
Pramipexole—Bradycardia—Methylprednisolone—gout	0.000204	0.000382	CcSEcCtD
Pramipexole—Muscular weakness—Prednisone—gout	0.000202	0.000379	CcSEcCtD
Pramipexole—Rhinitis—Methylprednisolone—gout	0.000201	0.000376	CcSEcCtD
Pramipexole—Diarrhoea—Naproxen—gout	0.0002	0.000375	CcSEcCtD
Pramipexole—Abdominal distension—Prednisone—gout	0.000199	0.000374	CcSEcCtD
Pramipexole—Hallucination—Methylprednisolone—gout	0.000199	0.000374	CcSEcCtD
Pramipexole—Eye disorder—Hydrocortisone—gout	0.000199	0.000374	CcSEcCtD
Pramipexole—Nausea—Allopurinol—gout	0.000199	0.000372	CcSEcCtD
Pramipexole—Connective tissue disorder—Methylprednisolone—gout	0.000197	0.000369	CcSEcCtD
Pramipexole—Pancreatitis—Prednisone—gout	0.000194	0.000364	CcSEcCtD
Pramipexole—Dizziness—Naproxen—gout	0.000193	0.000362	CcSEcCtD
Pramipexole—Visual impairment—Methylprednisolone—gout	0.000193	0.000362	CcSEcCtD
Pramipexole—Immune system disorder—Hydrocortisone—gout	0.000193	0.000361	CcSEcCtD
Pramipexole—Erythema—Prednisolone—gout	0.00019	0.000356	CcSEcCtD
Pramipexole—Eye disorder—Methylprednisolone—gout	0.000187	0.000351	CcSEcCtD
Pramipexole—Mental disorder—Hydrocortisone—gout	0.000187	0.00035	CcSEcCtD
Pramipexole—Cardiac disorder—Methylprednisolone—gout	0.000186	0.000348	CcSEcCtD
Pramipexole—Vomiting—Naproxen—gout	0.000186	0.000348	CcSEcCtD
Pramipexole—Erythema—Hydrocortisone—gout	0.000186	0.000348	CcSEcCtD
Pramipexole—Malnutrition—Hydrocortisone—gout	0.000186	0.000348	CcSEcCtD
Pramipexole—Rash—Naproxen—gout	0.000184	0.000345	CcSEcCtD
Pramipexole—Dermatitis—Naproxen—gout	0.000184	0.000345	CcSEcCtD
Pramipexole—DRD3—G alpha (i) signalling events—POMC—gout	0.000183	0.00194	CbGpPWpGaD
Pramipexole—Headache—Naproxen—gout	0.000183	0.000343	CcSEcCtD
Pramipexole—Erectile dysfunction—Prednisone—gout	0.000182	0.000342	CcSEcCtD
Pramipexole—Angiopathy—Methylprednisolone—gout	0.000182	0.000341	CcSEcCtD
Pramipexole—Immune system disorder—Methylprednisolone—gout	0.000181	0.000339	CcSEcCtD
Pramipexole—Mediastinal disorder—Methylprednisolone—gout	0.00018	0.000338	CcSEcCtD
Pramipexole—Weight increased—Prednisone—gout	0.00018	0.000338	CcSEcCtD
Pramipexole—Weight decreased—Prednisone—gout	0.000179	0.000336	CcSEcCtD
Pramipexole—Vision blurred—Prednisolone—gout	0.000179	0.000336	CcSEcCtD
Pramipexole—Hyperglycaemia—Prednisone—gout	0.000179	0.000335	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisolone—gout	0.000176	0.000331	CcSEcCtD
Pramipexole—Depression—Prednisone—gout	0.000176	0.00033	CcSEcCtD
Pramipexole—Mental disorder—Methylprednisolone—gout	0.000175	0.000329	CcSEcCtD
Pramipexole—Erythema—Methylprednisolone—gout	0.000174	0.000327	CcSEcCtD
Pramipexole—Malnutrition—Methylprednisolone—gout	0.000174	0.000327	CcSEcCtD
Pramipexole—Acute coronary syndrome—Prednisone—gout	0.000174	0.000327	CcSEcCtD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—ABCG2—gout	0.000174	0.00184	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PRPS1—gout	0.000174	0.00184	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—HPRT1—gout	0.000174	0.00184	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PRPS2—gout	0.000174	0.00184	CbGpPWpGaD
Pramipexole—Nausea—Naproxen—gout	0.000173	0.000325	CcSEcCtD
Pramipexole—Myocardial infarction—Prednisone—gout	0.000173	0.000325	CcSEcCtD
Pramipexole—Neuropathy peripheral—Prednisone—gout	0.000173	0.000325	CcSEcCtD
Pramipexole—Ill-defined disorder—Hydrocortisone—gout	0.000172	0.000323	CcSEcCtD
Pramipexole—Malaise—Prednisolone—gout	0.000171	0.000321	CcSEcCtD
Pramipexole—Vertigo—Prednisolone—gout	0.000171	0.00032	CcSEcCtD
Pramipexole—Syncope—Prednisolone—gout	0.00017	0.000319	CcSEcCtD
Pramipexole—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.00017	0.0018	CbGpPWpGaD
Pramipexole—DRD5—GPCR ligand binding—POMC—gout	0.000169	0.00179	CbGpPWpGaD
Pramipexole—Malaise—Hydrocortisone—gout	0.000167	0.000314	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisolone—gout	0.000167	0.000313	CcSEcCtD
Pramipexole—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000167	0.00177	CbGpPWpGaD
Pramipexole—Vertigo—Hydrocortisone—gout	0.000167	0.000313	CcSEcCtD
Pramipexole—Syncope—Hydrocortisone—gout	0.000166	0.000312	CcSEcCtD
Pramipexole—ADRA2B—G alpha (i) signalling events—POMC—gout	0.000166	0.00175	CbGpPWpGaD
Pramipexole—Convulsion—Prednisolone—gout	0.000165	0.000309	CcSEcCtD
Pramipexole—DRD4—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000164	0.00174	CbGpPWpGaD
Pramipexole—Hypertension—Prednisolone—gout	0.000164	0.000308	CcSEcCtD
Pramipexole—Loss of consciousness—Hydrocortisone—gout	0.000163	0.000306	CcSEcCtD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—ABCG2—gout	0.000162	0.00172	CbGpPWpGaD
Pramipexole—Ill-defined disorder—Methylprednisolone—gout	0.000162	0.000303	CcSEcCtD
Pramipexole—Bradycardia—Prednisone—gout	0.000161	0.000303	CcSEcCtD
Pramipexole—Convulsion—Hydrocortisone—gout	0.000161	0.000301	CcSEcCtD
Pramipexole—Hypertension—Hydrocortisone—gout	0.00016	0.0003	CcSEcCtD
Pramipexole—Discomfort—Prednisolone—gout	0.00016	0.0003	CcSEcCtD
Pramipexole—HTR1A—G alpha (i) signalling events—POMC—gout	0.00016	0.00169	CbGpPWpGaD
Pramipexole—Myalgia—Hydrocortisone—gout	0.000158	0.000296	CcSEcCtD
Pramipexole—Hallucination—Prednisone—gout	0.000158	0.000296	CcSEcCtD
Pramipexole—Anxiety—Hydrocortisone—gout	0.000157	0.000295	CcSEcCtD
Pramipexole—Malaise—Methylprednisolone—gout	0.000157	0.000295	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	0.000157	0.000294	CcSEcCtD
Pramipexole—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000157	0.00166	CbGpPWpGaD
Pramipexole—Vertigo—Methylprednisolone—gout	0.000157	0.000294	CcSEcCtD
Pramipexole—Syncope—Methylprednisolone—gout	0.000156	0.000293	CcSEcCtD
Pramipexole—Discomfort—Hydrocortisone—gout	0.000156	0.000293	CcSEcCtD
Pramipexole—Connective tissue disorder—Prednisone—gout	0.000156	0.000292	CcSEcCtD
Pramipexole—Oedema—Prednisolone—gout	0.000155	0.000291	CcSEcCtD
Pramipexole—ADRA2C—G alpha (i) signalling events—POMC—gout	0.000155	0.00164	CbGpPWpGaD
Pramipexole—Loss of consciousness—Methylprednisolone—gout	0.000153	0.000287	CcSEcCtD
Pramipexole—Shock—Prednisolone—gout	0.000153	0.000286	CcSEcCtD
Pramipexole—Oedema—Hydrocortisone—gout	0.000151	0.000284	CcSEcCtD
Pramipexole—Tachycardia—Prednisolone—gout	0.000151	0.000284	CcSEcCtD
Pramipexole—Convulsion—Methylprednisolone—gout	0.000151	0.000283	CcSEcCtD
Pramipexole—Hypertension—Methylprednisolone—gout	0.000151	0.000282	CcSEcCtD
Pramipexole—Infection—Hydrocortisone—gout	0.00015	0.000282	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisolone—gout	0.00015	0.000281	CcSEcCtD
Pramipexole—Shock—Hydrocortisone—gout	0.000149	0.000279	CcSEcCtD
Pramipexole—Nervous system disorder—Hydrocortisone—gout	0.000149	0.000278	CcSEcCtD
Pramipexole—Arthralgia—Methylprednisolone—gout	0.000148	0.000278	CcSEcCtD
Pramipexole—Myalgia—Methylprednisolone—gout	0.000148	0.000278	CcSEcCtD
Pramipexole—Eye disorder—Prednisone—gout	0.000148	0.000278	CcSEcCtD
Pramipexole—Anxiety—Methylprednisolone—gout	0.000148	0.000277	CcSEcCtD
Pramipexole—Tachycardia—Hydrocortisone—gout	0.000148	0.000277	CcSEcCtD
Pramipexole—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000148	0.00156	CbGpPWpGaD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	0.000147	0.000276	CcSEcCtD
Pramipexole—Flushing—Prednisone—gout	0.000147	0.000276	CcSEcCtD
Pramipexole—Skin disorder—Hydrocortisone—gout	0.000147	0.000276	CcSEcCtD
Pramipexole—Discomfort—Methylprednisolone—gout	0.000147	0.000275	CcSEcCtD
Pramipexole—Hyperhidrosis—Hydrocortisone—gout	0.000146	0.000274	CcSEcCtD
Pramipexole—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000146	0.00154	CbGpPWpGaD
Pramipexole—Anorexia—Hydrocortisone—gout	0.000144	0.000271	CcSEcCtD
Pramipexole—Angiopathy—Prednisone—gout	0.000144	0.00027	CcSEcCtD
Pramipexole—Confusional state—Methylprednisolone—gout	0.000143	0.000269	CcSEcCtD
Pramipexole—Immune system disorder—Prednisone—gout	0.000143	0.000269	CcSEcCtD
Pramipexole—Hypotension—Hydrocortisone—gout	0.000141	0.000265	CcSEcCtD
Pramipexole—Infection—Methylprednisolone—gout	0.000141	0.000265	CcSEcCtD
Pramipexole—DRD2—G alpha (i) signalling events—POMC—gout	0.00014	0.00149	CbGpPWpGaD
Pramipexole—Insomnia—Prednisolone—gout	0.00014	0.000263	CcSEcCtD
Pramipexole—Alopecia—Prednisone—gout	0.00014	0.000263	CcSEcCtD
Pramipexole—Shock—Methylprednisolone—gout	0.00014	0.000262	CcSEcCtD
Pramipexole—Nervous system disorder—Methylprednisolone—gout	0.00014	0.000262	CcSEcCtD
Pramipexole—Paraesthesia—Prednisolone—gout	0.000139	0.000261	CcSEcCtD
Pramipexole—Mental disorder—Prednisone—gout	0.000139	0.000261	CcSEcCtD
Pramipexole—Tachycardia—Methylprednisolone—gout	0.000139	0.00026	CcSEcCtD
Pramipexole—Skin disorder—Methylprednisolone—gout	0.000138	0.000259	CcSEcCtD
Pramipexole—Erythema—Prednisone—gout	0.000138	0.000259	CcSEcCtD
Pramipexole—Malnutrition—Prednisone—gout	0.000138	0.000259	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Hydrocortisone—gout	0.000138	0.000259	CcSEcCtD
Pramipexole—Hyperhidrosis—Methylprednisolone—gout	0.000138	0.000258	CcSEcCtD
Pramipexole—Insomnia—Hydrocortisone—gout	0.000137	0.000257	CcSEcCtD
Pramipexole—Paraesthesia—Hydrocortisone—gout	0.000136	0.000255	CcSEcCtD
Pramipexole—Dyspepsia—Hydrocortisone—gout	0.000133	0.00025	CcSEcCtD
Pramipexole—Hypotension—Methylprednisolone—gout	0.000133	0.000249	CcSEcCtD
Pramipexole—Pain—Prednisolone—gout	0.000133	0.000249	CcSEcCtD
Pramipexole—Decreased appetite—Hydrocortisone—gout	0.000132	0.000247	CcSEcCtD
Pramipexole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000132	0.00139	CbGpPWpGaD
Pramipexole—Gastrointestinal disorder—Hydrocortisone—gout	0.000131	0.000245	CcSEcCtD
Pramipexole—Fatigue—Hydrocortisone—gout	0.000131	0.000245	CcSEcCtD
Pramipexole—Vision blurred—Prednisone—gout	0.00013	0.000244	CcSEcCtD
Pramipexole—HTR1D—GPCR ligand binding—POMC—gout	0.00013	0.00137	CbGpPWpGaD
Pramipexole—Musculoskeletal discomfort—Methylprednisolone—gout	0.00013	0.000243	CcSEcCtD
Pramipexole—Pain—Hydrocortisone—gout	0.000129	0.000243	CcSEcCtD
Pramipexole—Insomnia—Methylprednisolone—gout	0.000129	0.000241	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisone—gout	0.000128	0.00024	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisolone—gout	0.000128	0.00024	CcSEcCtD
Pramipexole—Paraesthesia—Methylprednisolone—gout	0.000128	0.00024	CcSEcCtD
Pramipexole—Anaemia—Prednisone—gout	0.000128	0.000239	CcSEcCtD
Pramipexole—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000127	0.00135	CbGpPWpGaD
Pramipexole—HTR1B—GPCR ligand binding—POMC—gout	0.000127	0.00135	CbGpPWpGaD
Pramipexole—Agitation—Prednisone—gout	0.000127	0.000238	CcSEcCtD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000126	0.00134	CbGpPWpGaD
Pramipexole—ADRA2A—G alpha (i) signalling events—POMC—gout	0.000126	0.00133	CbGpPWpGaD
Pramipexole—Dyspepsia—Methylprednisolone—gout	0.000125	0.000235	CcSEcCtD
Pramipexole—DRD4—GPCR ligand binding—POMC—gout	0.000125	0.00132	CbGpPWpGaD
Pramipexole—Feeling abnormal—Hydrocortisone—gout	0.000125	0.000234	CcSEcCtD
Pramipexole—Malaise—Prednisone—gout	0.000124	0.000233	CcSEcCtD
Pramipexole—Vertigo—Prednisone—gout	0.000124	0.000233	CcSEcCtD
Pramipexole—Gastrointestinal pain—Hydrocortisone—gout	0.000124	0.000232	CcSEcCtD
Pramipexole—Syncope—Prednisone—gout	0.000124	0.000232	CcSEcCtD
Pramipexole—Urticaria—Prednisolone—gout	0.000123	0.000231	CcSEcCtD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000123	0.0013	CbGpPWpGaD
Pramipexole—Fatigue—Methylprednisolone—gout	0.000123	0.00023	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisone—gout	0.000121	0.000228	CcSEcCtD
Pramipexole—Urticaria—Hydrocortisone—gout	0.00012	0.000226	CcSEcCtD
Pramipexole—Body temperature increased—Hydrocortisone—gout	0.00012	0.000224	CcSEcCtD
Pramipexole—Abdominal pain—Hydrocortisone—gout	0.00012	0.000224	CcSEcCtD
Pramipexole—Convulsion—Prednisone—gout	0.00012	0.000224	CcSEcCtD
Pramipexole—HTR2B—GPCR ligand binding—POMC—gout	0.000119	0.00126	CbGpPWpGaD
Pramipexole—Hypertension—Prednisone—gout	0.000119	0.000223	CcSEcCtD
Pramipexole—Arthralgia—Prednisone—gout	0.000118	0.00022	CcSEcCtD
Pramipexole—Myalgia—Prednisone—gout	0.000118	0.00022	CcSEcCtD
Pramipexole—Feeling abnormal—Methylprednisolone—gout	0.000117	0.00022	CcSEcCtD
Pramipexole—Anxiety—Prednisone—gout	0.000117	0.00022	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	0.000117	0.000219	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methylprednisolone—gout	0.000116	0.000218	CcSEcCtD
Pramipexole—Discomfort—Prednisone—gout	0.000116	0.000218	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisolone—gout	0.000114	0.000214	CcSEcCtD
Pramipexole—Urticaria—Methylprednisolone—gout	0.000113	0.000212	CcSEcCtD
Pramipexole—Oedema—Prednisone—gout	0.000113	0.000211	CcSEcCtD
Pramipexole—DRD1—GPCR ligand binding—POMC—gout	0.000113	0.00119	CbGpPWpGaD
Pramipexole—Abdominal pain—Methylprednisolone—gout	0.000112	0.000211	CcSEcCtD
Pramipexole—Infection—Prednisone—gout	0.000112	0.00021	CcSEcCtD
Pramipexole—Hypersensitivity—Hydrocortisone—gout	0.000112	0.000209	CcSEcCtD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.000112	0.00118	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—POMC—gout	0.000111	0.00118	CbGpPWpGaD
Pramipexole—Shock—Prednisone—gout	0.000111	0.000208	CcSEcCtD
Pramipexole—Nervous system disorder—Prednisone—gout	0.00011	0.000207	CcSEcCtD
Pramipexole—Tachycardia—Prednisone—gout	0.00011	0.000206	CcSEcCtD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—gout	0.00011	0.00116	CbGpPWpGaD
Pramipexole—Skin disorder—Prednisone—gout	0.000109	0.000205	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisone—gout	0.000109	0.000204	CcSEcCtD
Pramipexole—Asthenia—Hydrocortisone—gout	0.000109	0.000204	CcSEcCtD
Pramipexole—Anorexia—Prednisone—gout	0.000107	0.000201	CcSEcCtD
Pramipexole—Pruritus—Hydrocortisone—gout	0.000107	0.000201	CcSEcCtD
Pramipexole—Hypersensitivity—Methylprednisolone—gout	0.000105	0.000197	CcSEcCtD
Pramipexole—Diarrhoea—Hydrocortisone—gout	0.000104	0.000194	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Prednisone—gout	0.000103	0.000192	CcSEcCtD
Pramipexole—Dizziness—Prednisolone—gout	0.000103	0.000192	CcSEcCtD
Pramipexole—Asthenia—Methylprednisolone—gout	0.000102	0.000191	CcSEcCtD
Pramipexole—Insomnia—Prednisone—gout	0.000102	0.000191	CcSEcCtD
Pramipexole—Paraesthesia—Prednisone—gout	0.000101	0.00019	CcSEcCtD
Pramipexole—Pruritus—Methylprednisolone—gout	0.000101	0.000189	CcSEcCtD
Pramipexole—ADRA2B—GPCR ligand binding—POMC—gout	0.0001	0.00106	CbGpPWpGaD
Pramipexole—Dizziness—Hydrocortisone—gout	0.0001	0.000188	CcSEcCtD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—gout	9.99e-05	0.00106	CbGpPWpGaD
Pramipexole—Dyspepsia—Prednisone—gout	9.92e-05	0.000186	CcSEcCtD
Pramipexole—Decreased appetite—Prednisone—gout	9.79e-05	0.000184	CcSEcCtD
Pramipexole—Rash—Prednisolone—gout	9.78e-05	0.000183	CcSEcCtD
Pramipexole—Dermatitis—Prednisolone—gout	9.77e-05	0.000183	CcSEcCtD
Pramipexole—Diarrhoea—Methylprednisolone—gout	9.73e-05	0.000183	CcSEcCtD
Pramipexole—Fatigue—Prednisone—gout	9.71e-05	0.000182	CcSEcCtD
Pramipexole—Headache—Prednisolone—gout	9.71e-05	0.000182	CcSEcCtD
Pramipexole—HTR1A—GPCR ligand binding—POMC—gout	9.67e-05	0.00102	CbGpPWpGaD
Pramipexole—Constipation—Prednisone—gout	9.63e-05	0.000181	CcSEcCtD
Pramipexole—Vomiting—Hydrocortisone—gout	9.63e-05	0.000181	CcSEcCtD
Pramipexole—HTR2C—GPCR ligand binding—POMC—gout	9.62e-05	0.00102	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—POMC—gout	9.57e-05	0.00101	CbGpPWpGaD
Pramipexole—Rash—Hydrocortisone—gout	9.55e-05	0.000179	CcSEcCtD
Pramipexole—Dermatitis—Hydrocortisone—gout	9.54e-05	0.000179	CcSEcCtD
Pramipexole—Headache—Hydrocortisone—gout	9.49e-05	0.000178	CcSEcCtD
Pramipexole—Dizziness—Methylprednisolone—gout	9.41e-05	0.000176	CcSEcCtD
Pramipexole—ADRA2C—GPCR ligand binding—POMC—gout	9.36e-05	0.000992	CbGpPWpGaD
Pramipexole—Feeling abnormal—Prednisone—gout	9.28e-05	0.000174	CcSEcCtD
Pramipexole—Gastrointestinal pain—Prednisone—gout	9.21e-05	0.000173	CcSEcCtD
Pramipexole—Nausea—Prednisolone—gout	9.21e-05	0.000173	CcSEcCtD
Pramipexole—Vomiting—Methylprednisolone—gout	9.05e-05	0.00017	CcSEcCtD
Pramipexole—Nausea—Hydrocortisone—gout	8.99e-05	0.000169	CcSEcCtD
Pramipexole—Rash—Methylprednisolone—gout	8.97e-05	0.000168	CcSEcCtD
Pramipexole—Dermatitis—Methylprednisolone—gout	8.96e-05	0.000168	CcSEcCtD
Pramipexole—Urticaria—Prednisone—gout	8.95e-05	0.000168	CcSEcCtD
Pramipexole—Headache—Methylprednisolone—gout	8.91e-05	0.000167	CcSEcCtD
Pramipexole—Body temperature increased—Prednisone—gout	8.91e-05	0.000167	CcSEcCtD
Pramipexole—Abdominal pain—Prednisone—gout	8.91e-05	0.000167	CcSEcCtD
Pramipexole—DRD5—Signaling by GPCR—POMC—gout	8.69e-05	0.00092	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—POMC—gout	8.49e-05	0.0009	CbGpPWpGaD
Pramipexole—Nausea—Methylprednisolone—gout	8.45e-05	0.000158	CcSEcCtD
Pramipexole—HTR2A—GPCR ligand binding—POMC—gout	8.36e-05	0.000885	CbGpPWpGaD
Pramipexole—Hypersensitivity—Prednisone—gout	8.3e-05	0.000156	CcSEcCtD
Pramipexole—SLC22A2—Metabolism—ABCG2—gout	8.15e-05	0.000863	CbGpPWpGaD
Pramipexole—Asthenia—Prednisone—gout	8.08e-05	0.000152	CcSEcCtD
Pramipexole—Pruritus—Prednisone—gout	7.97e-05	0.000149	CcSEcCtD
Pramipexole—ADRA2C—Metabolism—ABCG2—gout	7.93e-05	0.00084	CbGpPWpGaD
Pramipexole—Diarrhoea—Prednisone—gout	7.71e-05	0.000145	CcSEcCtD
Pramipexole—ADRA2A—GPCR ligand binding—POMC—gout	7.6e-05	0.000805	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ABCG2—gout	7.59e-05	0.000805	CbGpPWpGaD
Pramipexole—Dizziness—Prednisone—gout	7.45e-05	0.00014	CcSEcCtD
Pramipexole—HTR1D—GPCR downstream signaling—POMC—gout	7.33e-05	0.000776	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—POMC—gout	7.18e-05	0.00076	CbGpPWpGaD
Pramipexole—Vomiting—Prednisone—gout	7.16e-05	0.000134	CcSEcCtD
Pramipexole—Rash—Prednisone—gout	7.1e-05	0.000133	CcSEcCtD
Pramipexole—Dermatitis—Prednisone—gout	7.1e-05	0.000133	CcSEcCtD
Pramipexole—DRD4—GPCR downstream signaling—POMC—gout	7.06e-05	0.000748	CbGpPWpGaD
Pramipexole—Headache—Prednisone—gout	7.06e-05	0.000132	CcSEcCtD
Pramipexole—HTR2B—GPCR downstream signaling—POMC—gout	6.74e-05	0.000714	CbGpPWpGaD
Pramipexole—Nausea—Prednisone—gout	6.69e-05	0.000125	CcSEcCtD
Pramipexole—HTR1D—Signaling by GPCR—POMC—gout	6.66e-05	0.000705	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—POMC—gout	6.52e-05	0.00069	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ABCG2—gout	6.44e-05	0.000682	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—POMC—gout	6.41e-05	0.000679	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—POMC—gout	6.36e-05	0.000673	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—POMC—gout	6.27e-05	0.000664	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—POMC—gout	6.12e-05	0.000648	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—POMC—gout	5.77e-05	0.000612	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—POMC—gout	5.7e-05	0.000603	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—POMC—gout	5.66e-05	0.0006	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—POMC—gout	5.47e-05	0.000579	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—POMC—gout	5.44e-05	0.000576	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—POMC—gout	5.29e-05	0.00056	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—POMC—gout	5.14e-05	0.000545	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—POMC—gout	5.13e-05	0.000544	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—POMC—gout	4.96e-05	0.000526	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—POMC—gout	4.94e-05	0.000523	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—POMC—gout	4.8e-05	0.000509	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—POMC—gout	4.8e-05	0.000508	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—POMC—gout	4.72e-05	0.0005	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—POMC—gout	4.36e-05	0.000462	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—POMC—gout	4.3e-05	0.000455	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—POMC—gout	4.29e-05	0.000454	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—POMC—gout	3.93e-05	0.000416	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—POMC—gout	3.9e-05	0.000413	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—POMC—gout	3.85e-05	0.000408	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—POMC—gout	3.79e-05	0.000401	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—POMC—gout	3.62e-05	0.000383	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—POMC—gout	3.49e-05	0.00037	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—POMC—gout	3.41e-05	0.000361	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—POMC—gout	3.39e-05	0.00036	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—POMC—gout	3.37e-05	0.000356	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—POMC—gout	3.25e-05	0.000345	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—POMC—gout	3.04e-05	0.000322	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—POMC—gout	2.93e-05	0.000311	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—POMC—gout	2.92e-05	0.000309	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—POMC—gout	2.84e-05	0.000301	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—POMC—gout	2.76e-05	0.000292	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—POMC—gout	2.58e-05	0.000273	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—POMC—gout	2.53e-05	0.000268	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—POMC—gout	2.31e-05	0.000244	CbGpPWpGaD
